DE69918152D1 - Behandlung von verdauungsstörungen - Google Patents

Behandlung von verdauungsstörungen

Info

Publication number
DE69918152D1
DE69918152D1 DE69918152T DE69918152T DE69918152D1 DE 69918152 D1 DE69918152 D1 DE 69918152D1 DE 69918152 T DE69918152 T DE 69918152T DE 69918152 T DE69918152 T DE 69918152T DE 69918152 D1 DE69918152 D1 DE 69918152D1
Authority
DE
Germany
Prior art keywords
dyspepsia
medicament
treatment
xanthophylls
prophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69918152T
Other languages
English (en)
Other versions
DE69918152T2 (de
Inventor
Ake Lignell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTRAREAL GUSTAVSBERG AB
Original Assignee
ASTRAREAL GUSTAVSBERG AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTRAREAL GUSTAVSBERG AB filed Critical ASTRAREAL GUSTAVSBERG AB
Publication of DE69918152D1 publication Critical patent/DE69918152D1/de
Application granted granted Critical
Publication of DE69918152T2 publication Critical patent/DE69918152T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69918152T 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen Expired - Lifetime DE69918152T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9803541 1998-10-16
SE9803541A SE524337C2 (sv) 1998-10-16 1998-10-16 Användning av åtminstone en typ av xantofyller för framställning av ett läkemedel för profylaktisk och/eller terapeutisk behandling av matsmältningsbesvär
PCT/EP1999/007551 WO2000023064A1 (en) 1998-10-16 1999-10-08 Treatment of dyspepsia

Publications (2)

Publication Number Publication Date
DE69918152D1 true DE69918152D1 (de) 2004-07-22
DE69918152T2 DE69918152T2 (de) 2005-07-07

Family

ID=20412979

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69918152T Expired - Lifetime DE69918152T2 (de) 1998-10-16 1999-10-08 Behandlung von verdauungsstörungen

Country Status (11)

Country Link
US (1) US6923967B1 (de)
EP (1) EP1121106B1 (de)
JP (1) JP2002527472A (de)
AT (1) ATE269065T1 (de)
AU (1) AU763995B2 (de)
CA (1) CA2346647C (de)
DE (1) DE69918152T2 (de)
ES (1) ES2222732T3 (de)
NO (1) NO330158B1 (de)
SE (1) SE524337C2 (de)
WO (1) WO2000023064A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4933097B2 (ja) * 2003-12-19 2012-05-16 株式会社メニコン 糖尿病および糖尿病合併症の治療・改善方法
US20090118229A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118227A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2014074770A2 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Balanced mixotrophy methods
WO2014074772A1 (en) 2012-11-09 2014-05-15 Heliae Development, Llc Mixotrophic, phototrophic, and heterotrophic combination methods and systems
WO2014208511A1 (ja) * 2013-06-27 2014-12-31 学校法人同志社 アスタキサンチン含有腸内フローラ改善組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57105145A (en) * 1980-12-23 1982-06-30 Koichi Tanaka Feed additive
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IL110139A0 (en) * 1993-06-28 1994-10-07 Howard Foundation Pharmaceutically-active antioxidants
US5886053A (en) 1995-02-03 1999-03-23 Basf Aktiengesellschaft Use of carotenoids for producing drugs for the treatment of dermatoses
JPH09124470A (ja) * 1995-10-26 1997-05-13 Suntory Ltd 抗ストレス組成物
SE522246C2 (sv) * 1997-02-27 2004-01-27 Astacarotene Ab Oralt preparat för profylaktisk och terapeutisk behandling av Helicobacter Sp. infektion

Also Published As

Publication number Publication date
EP1121106B1 (de) 2004-06-16
SE9803541L (sv) 2000-04-17
ATE269065T1 (de) 2004-07-15
NO20011667L (no) 2001-04-03
US6923967B1 (en) 2005-08-02
NO330158B1 (no) 2011-02-28
NO20011667D0 (no) 2001-04-03
WO2000023064A1 (en) 2000-04-27
AU763995B2 (en) 2003-08-07
ES2222732T3 (es) 2005-02-01
AU6201699A (en) 2000-05-08
CA2346647C (en) 2003-03-11
EP1121106A1 (de) 2001-08-08
JP2002527472A (ja) 2002-08-27
CA2346647A1 (en) 2000-04-27
DE69918152T2 (de) 2005-07-07
SE524337C2 (sv) 2004-07-27
SE9803541D0 (sv) 1998-10-16

Similar Documents

Publication Publication Date Title
ATE243030T1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
US6344214B1 (en) Method for retarding and ameliorating fever blisters and canker sores
JP4927723B2 (ja) 老化の皮膚徴候を治療するのに適した組成物
RO117590B1 (ro) Compozitie pentru tratamentul unei degenerari, boli colagenice sau inflamatorii
US20130028884A1 (en) Composition and method for treatment of bruising
SE454566B (sv) Farmaceutisk komposition innehallande en verksam mengd av vattenlosliga proteinaser som extraherats fran ett vattenlevande djur valt av ordningen euphausiaceae eller slektet mallotus
DE69918152D1 (de) Behandlung von verdauungsstörungen
US20070264311A1 (en) Cysteine Protease from Ginger (Zingiber) as a Food Improver and Anti-Inflammatory
SE9704590L (sv) Sätt att öka produktionen av och förbättra kvaliteten hos sperma
DE3750426D1 (de) Mittel zur Verbesserung spezifischer Eigenschaften des Blutes.
Fuller et al. Aortic connective tissue changes in miniature pigs fed a lipid-rich diet
ATE253357T1 (de) Bergamottin enthaltende zusammensetzungen zur erhöhung der oralen bioverfügbarkeit von pharmazeutika
HUP9902421A2 (hu) Nyálkahártya-viszkozitást optimalizáló és bélfunkciót stimuláló hatású készítmények
CA2405479A1 (en) Method of inhibiting the expression of inflammatory cytokines and chemokines
CN115590896A (zh) 低分子右旋糖酐牛黄酸和小球藻联合制备治疗皮肤相关疾病药物的应用
US5576005A (en) Effectiveness of wart removal by compositions including propolis
KR20150011763A (ko) 여드름 치료, 예방 또는 개선에 유효한 클로린 e6
AU2001278375A1 (en) Composition for pharmaceutical and cosmetic products
Jadhav et al. Vitamins as a Nutraceutical for Blindness
JP5063040B2 (ja) 血管新生阻害剤
RU94030216A (ru) Противовоспалительная общеукрепляющая лекарственная смесь из натуральных и растительных продуктов
DE10103271A1 (de) Pharmazeutische Formulierungen zur Erweichung von Bindegewebe, insbesondere zur Formkorrektur von Bindegewebe und Bindegewebestrukturen
CN118697812A (zh) 一种使用酶解工艺制备的改善心脑血管功能、抗肿瘤、提高免疫海洋生物制剂
RU94022334A (ru) Способ лечения и профилактики инвазионных заболеваний

Legal Events

Date Code Title Description
8364 No opposition during term of opposition